Bio Services
(This newly created category covers companies that provide solutions, supply bio equipment and instruments, and perform sample analysis, bio reagent supply, and sample testing.)
−1.56% today·36 stocks·2 sub-categories
Stocks
By market cap · 36 stocks
- 1
Thermo Fisher ScientificTMOScientific tools and outsourced biopharma services$231.22B−1.38% - 2
Agilent TechnologiesALaboratory instruments, diagnostics, and CrossLab services$43.45B−2.46% - 3
IQVIAIQVHealthcare intelligence and outsourced clinical research$43.08B−0.27% - 4
LabcorpLHClinical diagnostics and drug-development laboratory services$27.48B−0.38% - 5
MedpaceMEDPFull-service clinical trials for emerging biopharma sponsors$16.77B−1.81% - 6
Charles River LaboratoriesCRLResearch models and nonclinical drug-development testing$14.04B−1.69% - 7
ICONICLROperator of global drug and device trials$13.02B+0.11% - 8
Bio-TechneTECHMaker of life-science reagents and protein-analysis tools$11.33B−0.17% - 9
RepligenRGENBioprocessing tools for biologics manufacturing$9.95B−3.20% - 10
Twist BioscienceTWSTSilicon-based DNA synthesis and sequencing tools$8.80B−7.72% - 11
Caris Life SciencesCAIOncology molecular profiling for clinical and biopharma use$7.25B−2.82% - 12
AbCellera BiologicsABCLAntibody discovery platform and clinical pipeline$3.47B−8.51% - 13
ADMA BiologicsADMAMaker of ASCENIV and BIVIGAM immune globulins$2.16B−1.37% - 14
Maravai LifeSciencesMRVINucleic-acid and biologics testing supplier$2.12B−8.54% - 15
FortreaFTREClinical-trial services for drug developers$1.79B−0.34% - 16
AzentaAZTALife-sciences sample management and multiomics services$1.52B−1.93% - 17
Mesa LaboratoriesMLABLife-science quality-control tools and indicators$722.4M+0.33% - 18
OmniAbOABIAntibody-discovery platform for partner therapeutics$648.0M−3.04% - 19
CerusCERSMaker of the INTERCEPT pathogen-reduction blood system$534.0M−2.39% - 20
EvolentEVHManages oncology, cardiology, and MSK care for insurers$517.4M0.00% - 21
NeoGenomicsNEOCancer-testing laboratory network for community oncologists$463.8M−3.19% - 22
Ginkgo BioworksDNAContract engineer of living cells and lab automation$454.7M−3.99% - 23
PacBioPACBHiFi long-read sequencing systems$434.8M−10.00% - 24
Alpha TeknovaTKNOCustom life-science reagent manufacturer$381.7M−2.74% - 25
Emergent BioSolutionsEBSNaloxone and medical-countermeasure supplier$304.9M−0.42% - 26
Standard BioToolsLABMass-cytometry and microfluidic genomics tools$251.3M−2.14% - 27
Lifecore BiomedicalLFCRSterile injectable CDMO with HA expertise$170.3M−0.11% - 28
SeerSEERNanoparticle-driven proteomics research platform$108.9M−1.00% - 29
Rapid Micro BiosystemsRPIDAutomated microbial quality control for life-sciences manufacturing$71.2M−2.48% - 30
eXoZymesEXOZCell-free enzyme systems for small molecules$66.5M+2.30% - 31
PrecipioPRPOHematologic-cancer diagnostics and proprietary lab products$51.5M−1.95% - 32
Harvard BioscienceHBIOPreclinical and cellular research tools$35.8M+0.13% - 33
20/20 BiolabsAIDXProtein-biomarker cancer and inflammation testing$7.6M+1.63% - 34
ProfusaPFSATissue-integrated biosensors for continuous body chemistry$3.2M−31.84% - 35
Tivic Health SystemsTIVCClinical-stage immunotherapy developer$279.2K−10.46% - 36
iSpecimenISPCAnnotated human biospecimen procurement marketplace$213.8K−3.13%